title: Combining methylphenidate and clonidine: a clinically sound medication option.
authors.affiliation: Pediatric Psychopharmacology Unit, Massachusetts General Hospital, Harvard Medical School, Boston 02114, USA.
authors.forename: T E
authors.initials: TE
authors.lastname: Wilens
authors.forename: T J
authors.initials: TJ
authors.lastname: Spencer
authors.forename: J M
authors.initials: JM
authors.lastname: Swanson
authors.forename: D F
authors.initials: DF
authors.lastname: Connor
authors.forename: D
authors.initials: D
authors.lastname: Cantwell
mesh_terms: D000293:Adolescent; D016907:Adverse Drug Reaction Reporting Systems; D000374:Aggression; D000959:Antihypertensive Agents / Q000009:adverse effects* / Q000494:pharmacology / Q000627:therapeutic use; D001289:Attention Deficit Disorder with Hyperactivity / Q000188:drug therapy*; D000697:Central Nervous System Stimulants / Q000009:adverse effects* / Q000494:pharmacology / Q000627:therapeutic use; D002648:Child; D002669:Child Welfare; D003000:Clonidine / Q000009:adverse effects* / Q000494:pharmacology / Q000627:therapeutic use; D004347:Drug Interactions; D004359:Drug Therapy, Combination; D006801:Humans; D008774:Methylphenidate / Q000009:adverse effects* / Q000494:pharmacology / Q000627:therapeutic use; D012449:Safety
chemical_list: D000959:Antihypertensive Agents; D000697:Central Nervous System Stimulants; D008774:Methylphenidate; D003000:Clonidine